Literature DB >> 31399520

c-Abl-Mediated Tyrosine Phosphorylation of PARP1 Is Crucial for Expression of Proinflammatory Genes.

Ameer Ali Bohio1,2, Aman Sattout1,2, Ruoxi Wang1,2, Ke Wang1,2, Rajiv Kumar Sah3, Xiaolan Guo1,2, Xianlu Zeng1,2, Yueshuang Ke1,2, Istvan Boldogh4, Xueqing Ba5,2.   

Abstract

Poly(ADP-ribosyl)ation is a rapid and transient posttranslational protein modification mostly catalyzed by poly(ADP-ribose) polymerase-1 (PARP1). Fundamental roles of activated PARP1 in DNA damage repair and cellular response pathways are well established; however, the precise mechanisms by which PARP1 is activated independent of DNA damage, and thereby playing a role in expression of inflammatory genes, remain poorly understood. In this study, we show that, in response to LPS or TNF-α exposure, the nonreceptor tyrosine kinase c-Abl undergoes nuclear translocation and interacts with and phosphorylates PARP1 at the conserved Y829 site. Tyrosine-phosphorylated PARP1 is required for protein poly(ADP-ribosyl)ation of RelA/p65 and NF-κB-dependent expression of proinflammatory genes in murine RAW 264.7 macrophages, human monocytic THP1 cells, or mouse lungs. Furthermore, LPS-induced airway lung inflammation was reduced by inhibition of c-Abl activity. The present study elucidated a novel signaling pathway to activate PARP1 and regulate gene expression, suggesting that blocking the interaction of c-Abl with PARP1 or pharmaceutical inhibition of c-Abl may improve the outcomes of PARP1 activation-mediated inflammatory diseases.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31399520      PMCID: PMC6731455          DOI: 10.4049/jimmunol.1801616

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  62 in total

1.  Regulation of poly(ADP-ribose) polymerase-1 by DNA structure-specific binding.

Authors:  Irina Lonskaya; Vladimir N Potaman; Luda S Shlyakhtenko; Elena A Oussatcheva; Yuri L Lyubchenko; Viatcheslav A Soldatenkov
Journal:  J Biol Chem       Date:  2005-02-28       Impact factor: 5.157

Review 2.  Poly(ADP-ribose) polymerases: homology, structural domains and functions. Novel therapeutical applications.

Authors:  Paul A Nguewa; Miguel A Fuertes; Basilio Valladares; Carlos Alonso; José M Pérez
Journal:  Prog Biophys Mol Biol       Date:  2005-05       Impact factor: 3.667

3.  Signaling function of PSGL-1 in neutrophil: tyrosine-phosphorylation-dependent and c-Abl-involved alteration in the F-actin-based cytoskeleton.

Authors:  Xueqing Ba; Cuixia Chen; Yanguang Gao; Xianlu Zeng
Journal:  J Cell Biochem       Date:  2005-02-01       Impact factor: 4.429

4.  Poly(ADP-ribose) polymerase-1 regulates activation of activator protein-1 in murine fibroblasts.

Authors:  Teresa L Andreone; Michael O'Connor; Alvin Denenberg; Paul W Hake; Basilia Zingarelli
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

Review 5.  The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.

Authors:  László Virág; Csaba Szabó
Journal:  Pharmacol Rev       Date:  2002-09       Impact factor: 25.468

6.  Coenzymatic activity of randomly broken or intact double-stranded DNAs in auto and histone H1 trans-poly(ADP-ribosylation), catalyzed by poly(ADP-ribose) polymerase (PARP I).

Authors:  Ernest Kun; Eva Kirsten; Charles P Ordahl
Journal:  J Biol Chem       Date:  2002-08-29       Impact factor: 5.157

Review 7.  The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders.

Authors:  P O Hassa; M O Hottiger
Journal:  Cell Mol Life Sci       Date:  2002-09       Impact factor: 9.261

8.  Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock.

Authors:  Balazs Veres; Ferenc Gallyas; Gabor Varbiro; Zoltan Berente; Erzsebet Osz; Gyorgy Szekeres; Csaba Szabo; Balazs Sumegi
Journal:  Biochem Pharmacol       Date:  2003-04-15       Impact factor: 5.858

Review 9.  PARP goes transcription.

Authors:  W Lee Kraus; John T Lis
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

10.  Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci.

Authors:  Alexei Tulin; Allan Spradling
Journal:  Science       Date:  2003-01-24       Impact factor: 47.728

View more
  15 in total

1.  Effects of the PARP Inhibitor Olaparib on the Response of Human Peripheral Blood Leukocytes to Bacterial Challenge or Oxidative Stress.

Authors:  Sidneia Sousa Santos; Milena Karina Coló Brunialti; Larissa de Oliveira Cavalcanti Peres Rodrigues; Ana Maria Alvim Liberatore; Ivan Hong Jun Koh; Vanessa Martins; Francisco Garcia Soriano; Csaba Szabo; Reinaldo Salomão
Journal:  Biomolecules       Date:  2022-06-04

Review 2.  Protein post-translational modifications in the regulation of cancer hallmarks.

Authors:  Haiying Wang; Liqian Yang; Minghui Liu; Jianyuan Luo
Journal:  Cancer Gene Ther       Date:  2022-04-07       Impact factor: 5.854

Review 3.  PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis.

Authors:  Weronika Wasyluk; Agnieszka Zwolak
Journal:  J Inflamm Res       Date:  2021-05-06

Review 4.  The impact of PARPs and ADP-ribosylation on inflammation and host-pathogen interactions.

Authors:  Anthony R Fehr; Sasha A Singh; Catherine M Kerr; Shin Mukai; Hideyuki Higashi; Masanori Aikawa
Journal:  Genes Dev       Date:  2020-02-06       Impact factor: 11.361

Review 5.  The Role of PARP1 in Monocyte and Macrophage Commitment and Specification: Future Perspectives and Limitations for the Treatment of Monocyte and Macrophage Relevant Diseases with PARP Inhibitors.

Authors:  Maciej Sobczak; Marharyta Zyma; Agnieszka Robaszkiewicz
Journal:  Cells       Date:  2020-09-06       Impact factor: 6.600

6.  Arg mediates LPS-induced disruption of the pulmonary endothelial barrier.

Authors:  Alicia N Rizzo; Patrick Belvitch; Regaina Demeritte; Joe G N Garcia; Eleftheria Letsiou; Steven M Dudek
Journal:  Vascul Pharmacol       Date:  2020-03-30       Impact factor: 5.773

7.  Enzymatically inactive OGG1 binds to DNA and steers base excision repair toward gene transcription.

Authors:  Wenjing Hao; Jing Wang; Yuanhang Zhang; Chenxin Wang; Lan Xia; Wenhe Zhang; Muhammad Zafar; Ju-Yong Kang; Ruoxi Wang; Ameer Ali Bohio; Lang Pan; Xianlu Zeng; Min Wei; Istvan Boldogh; Xueqing Ba
Journal:  FASEB J       Date:  2020-05-06       Impact factor: 5.191

Review 8.  The Role of PARPs in Inflammation-and Metabolic-Related Diseases: Molecular Mechanisms and Beyond.

Authors:  Yueshuang Ke; Chenxin Wang; Jiaqi Zhang; Xiyue Zhong; Ruoxi Wang; Xianlu Zeng; Xueqing Ba
Journal:  Cells       Date:  2019-09-06       Impact factor: 6.600

9.  Poly(ADP-ribosyl)ation enhances HuR oligomerization and contributes to pro-inflammatory gene mRNA stabilization.

Authors:  Yueshuang Ke; Xueping Lv; Xingyue Fu; Jing Zhang; Ameer Ali Bohio; Xianlu Zeng; Wenjing Hao; Ruoxi Wang; Istvan Boldogh; Xueqing Ba
Journal:  Cell Mol Life Sci       Date:  2020-08-13       Impact factor: 9.261

10.  New Insights into the Significance of PARP-1 Activation: Flow Cytometric Detection of Poly(ADP-Ribose) as a Marker of Bovine Intramammary Infection.

Authors:  Giovanna De Matteis; Francesco Grandoni; Michele Zampieri; Anna Reale; Maria Carmela Scatà
Journal:  Cells       Date:  2021-03-09       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.